Thomas J. Harrington
Expertise in
35
conditions

Dr. Thomas J. Harrington

Hematology Oncology | Hematology
1475 Northwest 12th Avenue, 
Miami, FL 
Accepting New Patients
Offers Telehealth
Expertise in
35
conditions
1475 Northwest 12th Avenue, 
Miami, FL 

Overview

Thomas Harrington is a Hematologist Oncology specialist and a Hematologist practicing medicine in Miami, Florida.

Dr. Harrington is highly rated in 35 conditions, according to our data. His clinical expertise encompasses Sickle Cell Disease, Hemoglobin SC Disease, Hemoglobinopathy, Bone Marrow Aspiration, and Cerebral Artery Bypass Surgery.

He is actively involved in clinical research, co-authoring 16 peer reviewed articles and participating in 1 clinical trial. Dr. Harrington is currently accepting new patients.

Specialties

Hematology Oncology
Hematology

Licenses

Internal Medicine in FL

Fellowships

JMH Division of Hematology/Oncology, Hematology - 1991
University of Minnesota Hospitals, Medical Oncology - 1992

Hospital Affiliations

Jackson Health System

Languages Spoken

English
Spanish

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
AvMed
  • HMO
  • POS
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Florida Blue
  • EPO
  • PPO
Guardian Life Insurance Company
  • MEDICARE PDP
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

Health Options
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Icare Independent Care Health Plan
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
MetLife
  • PPO
Neighborhood
  • MANAGED MEDICAID PLAN
  • MEDICARE ASSISTANCE PROGRAM
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
Oscar
  • EPO
  • HMO
  • PPO
Simply Healthcare
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
Sunshine Health
  • EPO
  • HMO
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 21 Less Insurance Carriers -

Locations

1475 Northwest 12th Avenue, Miami, FL 33136

Additional Areas of Focus

Dr. Harrington has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Merkel Cell Carcinoma
Anemia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase II Randomized, Double-Blind, Placebo-Controlled Multi-Center Study to Assess the Safety, Tolerability, and Efficacy of Riociguat in Patients With Sickle Cell Diseases
A Phase II Randomized, Double-Blind, Placebo-Controlled Multi-Center Study to Assess the Safety, Tolerability, and Efficacy of Riociguat in Patients With Sickle Cell Diseases
Enrollment Status: Completed
Publish Date: July 19, 2023
Intervention Type: Drug
Study Drug: Riociguat
Study Phase: Phase 2

16 Total Publications

A Descriptive 5-Year Analysis of the Demographics and Therapies for Patients With Immune Thrombotic Thrombocytopenic Purpura in the USA: A Multicenter Study of 390 Disease Episodes From 2017 to 2021.
A Descriptive 5-Year Analysis of the Demographics and Therapies for Patients With Immune Thrombotic Thrombocytopenic Purpura in the USA: A Multicenter Study of 390 Disease Episodes From 2017 to 2021.
Journal: Journal of clinical apheresis
Published: December 26, 2024
Similar Doctors
Expertise in
21
conditions
Dr. Izidore S. Lossos
Hematology Oncology | Hematology
Expertise in
21
conditions
Dr. Izidore S. Lossos
Hematology Oncology | Hematology
Referral may be required
1475 Northwest 12th Avenue, 
Miami, FL 
 (0.1 miles away)
305-243-5302
Languages Spoken:
English, Hebrew, Russian, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Izidore Lossos is a Hematologist Oncology specialist and a Hematologist practicing medicine in Miami, Florida. Dr. Lossos is highly rated in 21 conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, Marginal Zone Lymphoma (MZL), B-Cell Lymphoma, Follicular Lymphoma, and Bone Marrow Transplant. Dr. Lossos is currently accepting new patients.

Expertise in
23
conditions
Dr. Mikkael A. Sekeres
Hematology Oncology | Hematology
Expertise in
23
conditions
Dr. Mikkael A. Sekeres
Hematology Oncology | Hematology
Referral may be required
1425 Northwest 10th Avenue, 
Miami, FL 
 (0.2 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

His research focuses on patients with myelodysplastic syndromes (MDS) and older adults with acute myeloid leukemia (AML). Dr. Sekeres is highly rated in 23 conditions, according to our data. His clinical expertise encompasses Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML), Leukemia, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Sekeres is currently accepting new patients.

Expertise in
26
conditions
Dr. Rafat Abonour
Hematology Oncology
Expertise in
26
conditions
Dr. Rafat Abonour
Hematology Oncology
Referral may be required
2111 Sole Mia Way 5th, 
Miami, FL 
 (8.5 miles away)
305-243-5302
Languages Spoken:
English, Arabic, French
See accepted insurances
Accepting New Patients
Offers Telehealth

Rafat Abonour is a Hematologist Oncology provider practicing medicine in Miami, Florida. Dr. Abonour is highly rated in 26 conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Smoldering Multiple Myeloma, Primary Amyloidosis, Relapsed Refractory Multiple Myeloma (RRMM), and Bone Marrow Transplant. Dr. Abonour is currently accepting new patients.

Frequently Asked Questions about Dr. Thomas J. Harrington

How do I make an appointment with Dr. Thomas J. Harrington?

You can book an appointment with Dr. Thomas J. Harrington by calling their office at 305-243-5302. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Thomas J. Harrington a top-rated expert for Sickle Cell Disease?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Thomas J. Harrington is classified as an Distinguished expert for Sickle Cell Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Thomas J. Harrington specialize in?

While Dr. Thomas J. Harrington is a Hematology Oncology, they have specific expertise in Sickle Cell Disease, Hemoglobin SC Disease, and Hemoglobinopathy. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology Oncology.

Does Dr. Thomas J. Harrington participate in research or clinical trials?

Yes. Dr. Thomas J. Harrington has published 16 articles and abstracts on conditions like Sickle Cell Disease. You can view a list of Dr. Thomas J. Harrington's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Thomas J. Harrington accept my insurance?

Dr. Thomas J. Harrington accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 305-243-5302 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Harrington's expertise for a condition
ConditionClose
    View All 7 Distinguished Conditions
    View All 28 Advanced Conditions
    View All 110 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile